69 related articles for article (PubMed ID: 3497381)
1. Adverse reactions reported following receipt of Haemophilus influenzae type b vaccine: an analysis after 1 year of marketing.
Milstien JB; Gross TP; Kuritsky JN
Pediatrics; 1987 Aug; 80(2):270-4. PubMed ID: 3497381
[TBL] [Abstract][Full Text] [Related]
2. Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia.
Meekison W; Hutcheon M; Guasparini R; Arnott M; Scheifele D; Grace M; Humphreys G; Barreto L
Can Dis Wkly Rep; 1989 Jul; 15(28):143-5. PubMed ID: 2791073
[No Abstract] [Full Text] [Related]
3. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Granoff DM; Osterholm MT
Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
[No Abstract] [Full Text] [Related]
4. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
5. Request for reports of disease after immunization with Hib polysaccharide vaccine.
FDA Drug Bull; 1986 Jun; 16(1):6-7. PubMed ID: 3488239
[No Abstract] [Full Text] [Related]
6. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
[TBL] [Abstract][Full Text] [Related]
7. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
[No Abstract] [Full Text] [Related]
8. National adverse drug reaction surveillance. 1986.
Faich GA; Dreis M; Tomita D
Arch Intern Med; 1988 Apr; 148(4):785-7. PubMed ID: 3355297
[TBL] [Abstract][Full Text] [Related]
9. b-CAPSA I Haemophilus influenzae, type b, capsular polysaccharide vaccine safety.
Black SB; Shinefield HR
Pediatrics; 1987 Mar; 79(3):321-5. PubMed ID: 3822630
[TBL] [Abstract][Full Text] [Related]
10. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
[TBL] [Abstract][Full Text] [Related]
11. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
[TBL] [Abstract][Full Text] [Related]
12. Immediate allergic reactions after vaccinations--a post-marketing surveillance review.
Zent O; Arras-Reiter C; Broeker M; Hennig R
Eur J Pediatr; 2002 Jan; 161(1):21-5. PubMed ID: 11808876
[TBL] [Abstract][Full Text] [Related]
13. Food and Drug Administration monitoring of adverse drug reactions.
Sills JM; Tanner LA; Milstien JB
Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
[TBL] [Abstract][Full Text] [Related]
14. Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1985 Jul; 27(692):61-2. PubMed ID: 3874344
[No Abstract] [Full Text] [Related]
15. Postmarketing surveillance of adverse reactions to ProHIBit vaccine in British Columbia.
CMAJ; 1989 Nov; 141(9):927-9. PubMed ID: 2804851
[TBL] [Abstract][Full Text] [Related]
16. Hib vaccine recommendations.
FDA Drug Bull; 1985 Aug; 15(2):18-9. PubMed ID: 3876955
[No Abstract] [Full Text] [Related]
17. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
[No Abstract] [Full Text] [Related]
19. Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002.
Begier EM; Burwen DR; Haber P; Ball R;
Clin Infect Dis; 2004 Mar; 38(6):771-9. PubMed ID: 14999618
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions and reporting.
Witte R
Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
[No Abstract] [Full Text] [Related]
[Next] [New Search]
